Q&A: JP Morgan’s new life sciences private capital leader on the bank’s expanding ambitions, vetting startups and Abu Dhabi’s biotech push

Longtime biotech entrepreneur and investor Stephen Squinto helped build biotech giants Regeneron and Alexion before moving to the investment world at OrbiMed Advisors. Now, one year into his appointment as the chief investment officer and managing partner of JP Morgan’s nascent Life Sciences Private Capital — the…
Click here to view original post

Advertisement — Advertise with Biotech Networks